IBB vs. HRTS ETF Comparison
Comparison of iShares Nasdaq Biotechnology Index Fund (IBB) to Tema Cardiovascular and Metabolic ETF (HRTS)
IBB
iShares Nasdaq Biotechnology Index Fund
IBB Description
The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by The NASDAQ OMX Group, Inc. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$136.10
Average Daily Volume
1,176,846
184
HRTS
Tema Cardiovascular and Metabolic ETF
HRTS Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.Grade (RS Rating)
Last Trade
$30.77
Average Daily Volume
14,144
36
Performance
Period | IBB | HRTS |
---|---|---|
30 Days | -5.49% | -9.25% |
60 Days | -8.03% | -11.27% |
90 Days | -8.01% | -12.29% |
12 Months | 14.75% | 15.50% |
20 Overlapping Holdings
Symbol | Grade | Weight in IBB | Weight in HRTS | Overlap | |
---|---|---|---|---|---|
AKRO | B | 0.18% | 1.28% | 0.18% | |
ALNY | D | 3.32% | 4.95% | 3.32% | |
AMGN | F | 7.32% | 5.11% | 5.11% | |
ARWR | D | 0.25% | 1.76% | 0.25% | |
BBIO | F | 0.34% | 3.69% | 0.34% | |
CRNX | C | 0.48% | 4.0% | 0.48% | |
CYTK | F | 0.62% | 3.47% | 0.62% | |
EWTX | C | 0.2% | 0.96% | 0.2% | |
IONS | F | 0.49% | 2.42% | 0.49% | |
KROS | D | 0.19% | 2.1% | 0.19% | |
MDGL | B | 0.59% | 1.46% | 0.59% | |
MIRM | B | 0.16% | 2.6% | 0.16% | |
MLYS | F | 0.03% | 1.89% | 0.03% | |
NTLA | F | 0.16% | 1.66% | 0.16% | |
RARE | F | 0.4% | 1.71% | 0.4% | |
RCKT | F | 0.13% | 1.8% | 0.13% | |
REGN | F | 5.67% | 2.37% | 2.37% | |
TERN | F | 0.04% | 0.7% | 0.04% | |
VERV | F | 0.04% | 0.64% | 0.04% | |
VRTX | D | 8.08% | 5.64% | 5.64% |
IBB Overweight 164 Positions Relative to HRTS
Symbol | Grade | Weight | |
---|---|---|---|
GILD | C | 9.77% | |
IQV | F | 3.75% | |
MTD | F | 2.58% | |
BIIB | F | 2.36% | |
ILMN | C | 2.27% | |
WAT | C | 2.22% | |
UTHR | C | 1.7% | |
NTRA | A | 1.52% | |
INCY | C | 1.49% | |
MRNA | F | 1.45% | |
NBIX | C | 1.22% | |
BMRN | F | 1.21% | |
INSM | C | 1.14% | |
TECH | F | 1.13% | |
CRL | D | 1.07% | |
PCVX | D | 1.03% | |
SRPT | F | 0.99% | |
EXEL | B | 0.97% | |
MEDP | D | 0.89% | |
ITCI | C | 0.85% | |
RVMD | C | 0.8% | |
RGEN | D | 0.75% | |
HALO | F | 0.73% | |
BPMC | B | 0.58% | |
BRKR | D | 0.56% | |
ROIV | C | 0.5% | |
RNA | C | 0.49% | |
ADMA | B | 0.48% | |
ALKS | C | 0.46% | |
KRYS | C | 0.44% | |
BHVN | D | 0.4% | |
CRSP | D | 0.4% | |
ACLX | C | 0.39% | |
AXSM | B | 0.38% | |
DNLI | D | 0.35% | |
RYTM | C | 0.34% | |
AGIO | C | 0.32% | |
PTCT | B | 0.32% | |
XENE | D | 0.31% | |
NUVL | C | 0.3% | |
MRUS | F | 0.3% | |
ACAD | C | 0.29% | |
APLS | F | 0.29% | |
FOLD | F | 0.29% | |
KYMR | D | 0.28% | |
VCYT | B | 0.28% | |
VCEL | B | 0.26% | |
TWST | F | 0.25% | |
IOVA | F | 0.23% | |
IDYA | F | 0.23% | |
PTGX | D | 0.23% | |
APGE | F | 0.21% | |
LGND | C | 0.21% | |
DYN | F | 0.21% | |
GERN | D | 0.21% | |
SWTX | C | 0.21% | |
VERA | C | 0.2% | |
WVE | C | 0.19% | |
FTRE | D | 0.19% | |
JANX | C | 0.19% | |
SRRK | C | 0.19% | |
BEAM | D | 0.19% | |
IMVT | F | 0.18% | |
MNKD | C | 0.18% | |
NRIX | C | 0.17% | |
GPCR | F | 0.17% | |
NVCR | C | 0.17% | |
DVAX | C | 0.17% | |
SMMT | D | 0.17% | |
XNCR | B | 0.16% | |
RXRX | F | 0.16% | |
TARS | C | 0.15% | |
BCRX | D | 0.15% | |
TXG | F | 0.15% | |
ARVN | F | 0.15% | |
MYGN | F | 0.14% | |
TVTX | C | 0.14% | |
ZYME | C | 0.14% | |
SNDX | F | 0.13% | |
NVAX | F | 0.13% | |
KURA | F | 0.12% | |
AUPH | B | 0.11% | |
CDNA | D | 0.11% | |
IRON | B | 0.1% | |
ARQT | B | 0.1% | |
KNSA | F | 0.09% | |
ETNB | C | 0.09% | |
DAWN | D | 0.09% | |
ELVN | D | 0.08% | |
PRTA | F | 0.08% | |
VIR | D | 0.08% | |
SPRY | C | 0.08% | |
RCUS | F | 0.08% | |
ADPT | C | 0.08% | |
CTKB | C | 0.08% | |
CSTL | D | 0.08% | |
COGT | D | 0.08% | |
IRWD | F | 0.07% | |
PLRX | D | 0.07% | |
AVXL | B | 0.07% | |
OLMA | F | 0.06% | |
PACB | F | 0.06% | |
CGEM | F | 0.06% | |
REPL | D | 0.06% | |
MRVI | F | 0.06% | |
RLAY | F | 0.06% | |
NUVB | C | 0.06% | |
ORIC | F | 0.05% | |
RGNX | D | 0.05% | |
URGN | F | 0.05% | |
ARCT | F | 0.05% | |
YMAB | F | 0.05% | |
ERAS | C | 0.05% | |
HUMA | F | 0.05% | |
OPK | C | 0.05% | |
QTRX | F | 0.05% | |
ABUS | D | 0.05% | |
ANAB | F | 0.05% | |
TSHA | C | 0.04% | |
FLGT | F | 0.04% | |
SLRN | F | 0.04% | |
RVNC | F | 0.04% | |
ALLO | F | 0.04% | |
TRML | D | 0.04% | |
TBPH | B | 0.04% | |
ALEC | F | 0.04% | |
ITOS | F | 0.03% | |
AMLX | C | 0.03% | |
SAGE | F | 0.03% | |
VNDA | C | 0.03% | |
DNA | F | 0.03% | |
QURE | C | 0.03% | |
PHAT | F | 0.03% | |
VYGR | F | 0.03% | |
KALV | F | 0.03% | |
MXCT | D | 0.03% | |
SANA | F | 0.03% | |
FDMT | F | 0.03% | |
MGTX | C | 0.03% | |
SVRA | F | 0.03% | |
OKUR | F | 0.02% | |
ATAI | C | 0.02% | |
ACRS | B | 0.02% | |
CABA | F | 0.02% | |
NAUT | F | 0.02% | |
CRBU | D | 0.02% | |
TNGX | F | 0.02% | |
FULC | F | 0.02% | |
PRME | F | 0.02% | |
THRD | F | 0.02% | |
BMEA | F | 0.02% | |
ZNTL | F | 0.02% | |
MGNX | F | 0.02% | |
AVIR | F | 0.02% | |
EDIT | F | 0.02% | |
OVID | F | 0.01% | |
BLUE | F | 0.01% | |
CHRS | D | 0.01% | |
PGEN | F | 0.01% | |
VTYX | F | 0.01% | |
LYEL | F | 0.01% | |
MRNS | F | 0.0% | |
ALXO | F | 0.0% | |
RAPT | F | 0.0% |
IBB: Top Represented Industries & Keywords
HRTS: Top Represented Industries & Keywords